Concepedia

Author

Peihua Lu

Beijing Dao Pei HospitalORCID

Also Known As

Daobin Zhou, Jianqiang Li, P H Lu, P. Lu, Pei H. Lu, Pei-Hua Lu, Pei-hua Lu, Peihua LU, Peihua Lu, Xian Zhang

135

Publications

2.4K

Citations

24

H-Index

26

Concepts

All Affiliations

Beijing Dao Pei HospitalPeking University People's HospitalPeking UniversityInstitute of Hematology & Blood Diseases HospitalLuye Pharma (China)
PL

About

Peihua Lu is an author at Beijing Dao Pei Hospital specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

588

2

Cellular Therapies

5

5

511

3

Health Sciences

3

3

74

4

Blood Transplantation

1

1

206

5

Cell Biology

1

1

15

Peihua Lu

×

32

Publications

1.9K

Citations

19

H-Index

YearCitations

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

Peihua Lu, Robert S. Negrin

The Journal of Immunology

1994

432

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Jing Pan, Jieyu Yang, Biping Deng,

Leukemia

2017

231

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Xian Zhang, Xin‐an Lu, Junfang Yang,

Blood Advances

2020

206

Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia

Xiangyu Zhao, Junfang Yang, Xian Zhang,

Molecular Therapy — Oncolytics

2020

117

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma

Luan Sun, Fang Gao, Zhanhui Gao,

Journal for ImmunoTherapy of Cancer

2021

102

Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group

Lan‐Ping Xu, Peihua Lu, Depei Wu,

Bone Marrow Transplantation

2021

90

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

Junfang Yang, Jiaping He, Xian Zhang,

Blood Cancer Journal

2022

90

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Deyan Liu, Ruijuan Sun,

Frontiers in Immunology

2021

63

Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo

Jin‐Yuan Ho, Lin Wang, Ying Liu,

Molecular Therapy — Methods & Clinical Development

2021

54

Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies

Yu Zhao, Zhongfeng Liu, Xuan Wang,

Clinical Cancer Research

2019

47

Page 1